SCHEMBL12037333

SCHEMBL12037333

c1ccc2c(-c3ccc4oc5ccc(-c6ccc7cc(-c8ccc9c%10ccccc%10c%10ccccc%10c9c8)ccc7c6)cc5c4c3)cccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.40
▸ ACMSD Q8TDX5 1/20 0.40
▸ KDM4E B2RXH2 6/20 0.40
▸ MAPT P10636 5/20 0.40
▸ HSD17B10 Q99714 4/20 0.40
▸ HPGD P15428 3/20 0.40
▸ TSHR P16473 2/20 0.40
▸ GLA P06280 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ PIM1 P11309 2/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ CYP1A1 P04798 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12037271 0.96 PIM1 (0.42) MCL1ACMSDKDM4EMAPTHSD17B10
SCHEMBL12037330 0.96 MCL1 (0.40) MCL1ACMSDKDM4EMAPTHSD17B10
SCHEMBL12037270 0.92 PIM1 (0.42) MCL1ACMSDKDM4EMAPTHSD17B10
SCHEMBL12037242 0.92 KDM4E (0.41) MCL1ACMSDKDM4EMAPTHSD17B10
SCHEMBL12037138 0.91 MCL1 (0.40) MCL1ACMSDKDM4EMAPTHSD17B10
SCHEMBL12071358 0.91 KDM4E (0.47) MCL1ACMSDKDM4EMAPTHSD17B10
SCHEMBL25052390 0.90 ALOX5 (0.43) MCL1ACMSDKDM4EMAPTHSD17B10
SCHEMBL12037407 0.90 KDM4E (0.45) KDM4EMAPTHSD17B10HPGDTSHR
SCHEMBL12037296 0.90 KDM4E (0.45) KDM4EMAPTHSD17B10HPGDTSHR
SCHEMBL13979514 0.89 MCL1 (0.47) MCL1ACMSDKDM4EMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8940412-B2 Material for organic electroluminescent element, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2015-01-27 — — US disclosed
US-8940412-B2 Material for organic electroluminescent element, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2015-01-27 — — US disclosed
US-20110315965-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2011-12-29 — — US disclosed
US-20110315965-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2011-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110315965-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT LEF1, TERF2, BPTF MCL1 3910/4885ACMSD 2481/4885KDM4E 1891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback